Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Tinnitus
NCT03336398Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in tinnitus, sponsored by New York State Psychiatric Institute. Started Sep 2019; status: completed.
02
Drugs
ketamine
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT03336398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336398.